Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (361-370 of 368) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 368 results.
Haematologica|November 13, 2025
The comprehensive landscape of <i>TTMV::RARA</i> fusion-driven acute myeloid leukemia: from viral integration mechanisms to clinical outcomesShu Sun, Yongjing Liu, Qing-Yu Xu, et al.
American Journal of Hematology|May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA GroupJiajia Pan, Chunmei Fu, Qing Ling, et al.
The Lancet. Haematology|November 5, 2025
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 studyRuben Mesa, Harinder Gill, Lei Zhang, et al.
Leukemia|March 27, 2023
Validation of the imatinib-therapy failure modelXiaoshuai Zhang, Robert Peter Gale, Bingcheng Liu, et al.
Blood|July 24, 2024
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APLXiaosu Zhou, Xue Chen, Jiaqi Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2024
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective StudyXiaoshuai Zhang, Na Xu, Yunfan Yang, et al.
Blood|July 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyXiaoshuai Zhang, Bingcheng Liu, Jian Huang, et al.
Blood|August 14, 2025
Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic LeukemiaXiaosu Zhou, Jiaqi Chen, Yan-Lai Tang, et al.
Pageof 37

Showing results (361-370 of 368) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 368 results.
Haematologica|November 13, 2025
The comprehensive landscape of <i>TTMV::RARA</i> fusion-driven acute myeloid leukemia: from viral integration mechanisms to clinical outcomesShu Sun, Yongjing Liu, Qing-Yu Xu, et al.
American Journal of Hematology|May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA GroupJiajia Pan, Chunmei Fu, Qing Ling, et al.
The Lancet. Haematology|November 5, 2025
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 studyRuben Mesa, Harinder Gill, Lei Zhang, et al.
Leukemia|March 27, 2023
Validation of the imatinib-therapy failure modelXiaoshuai Zhang, Robert Peter Gale, Bingcheng Liu, et al.
Blood|July 24, 2024
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APLXiaosu Zhou, Xue Chen, Jiaqi Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2024
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective StudyXiaoshuai Zhang, Na Xu, Yunfan Yang, et al.
Blood|July 24, 2024
A predictive model for therapy failure in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyXiaoshuai Zhang, Bingcheng Liu, Jian Huang, et al.
Blood|August 14, 2025
Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic LeukemiaXiaosu Zhou, Jiaqi Chen, Yan-Lai Tang, et al.
Pageof 37